A top priority in pre-eclampsia research: development of a reliable and inexpensive urinary screening test

Marco Scioscia; Gustaaf A. Dekker; Gérard Chaouat; Lalita Dawonauth; Ralf Dechend; Debra Goldman-Wohl; Erry Gumilar; S. Ananth Karumanchi; Douglas B. Kell; Thomas W. Rademacher; Sarah Robertson; Shigeru Saito; Sicco Scherjon; Anne C. Staff; Manu Vatish; Pierre Yves Robillard

doi:10.1016/S2214-109X(19)30319-5

A top priority in pre-eclampsia research: development of a reliable and inexpensive urinary screening test

Marco Scioscia, Gustaaf A. Dekker, Gérard Chaouat, Lalita Dawonauth, Ralf Dechend, Debra Goldman-Wohl, Erry Gumilar, S. Ananth Karumanchi, Douglas B. Kell, Thomas W. Rademacher, Sarah Robertson, Shigeru Saito, Sicco Scherjon, Anne C. Staff, Manu Vatish, Pierre Yves Robillard

Member of the Board

Research output: Contribution to journal › Comment/debate

8 Scopus citations

Original language	English
Pages (from-to)	e1312-e1313
Journal	The Lancet Global Health
Volume	7
Issue number	10
DOIs	https://doi.org/10.1016/S2214-109X(19)30319-5
State	Published - 2019/10

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/S2214-109X(19)30319-5

Cite this

Scioscia, M., Dekker, G. A., Chaouat, G., Dawonauth, L., Dechend, R., Goldman-Wohl, D., Gumilar, E., Karumanchi, S. A., Kell, D. B., Rademacher, T. W., Robertson, S., Saito, S., Scherjon, S., Staff, A. C., Vatish, M., & Robillard, P. Y. (2019). A top priority in pre-eclampsia research: development of a reliable and inexpensive urinary screening test. The Lancet Global Health, 7(10), e1312-e1313. https://doi.org/10.1016/S2214-109X(19)30319-5

@article{f175a24277854f63bff5b90bd5cc8c7b,

title = "A top priority in pre-eclampsia research: development of a reliable and inexpensive urinary screening test",

author = "Marco Scioscia and Dekker, {Gustaaf A.} and G{\'e}rard Chaouat and Lalita Dawonauth and Ralf Dechend and Debra Goldman-Wohl and Erry Gumilar and Karumanchi, {S. Ananth} and Kell, {Douglas B.} and Rademacher, {Thomas W.} and Sarah Robertson and Shigeru Saito and Sicco Scherjon and Staff, {Anne C.} and Manu Vatish and Robillard, {Pierre Yves}",

note = "Funding Information: TWR reports being a co-author on inositol phosphoglycans pre-eclampsia publications while on the University College London Medical School board. TWR was a coinventor on an InositolPhospho Glycan pre-eclampsia diagnostic patent, which has now lapsed. TWR provides laboratory reagents to academic groups for pre-eclampsia clinical trials. SAK reports consultancy work for Roche and Thermofisher and receiving a research grant from Siemens during the writing of this Comment; being a founder and advisory board member of Aggamin Pharmaceuticals outside the submitted work; Preeclampsia Biomarker patents with royalties paid to Beth Israel Deaconess Medical Center; and being a member of the Scientific Advisory Board for the Pre-eclampsia Foundation. All other authors declare no competing interests.",

year = "2019",

month = oct,

doi = "10.1016/S2214-109X(19)30319-5",

language = "英語",

volume = "7",

pages = "e1312--e1313",

journal = "The Lancet Global Health",

issn = "2214-109X",

publisher = "Elsevier Ltd.",

number = "10",

}

Scioscia, M, Dekker, GA, Chaouat, G, Dawonauth, L, Dechend, R, Goldman-Wohl, D, Gumilar, E, Karumanchi, SA, Kell, DB, Rademacher, TW, Robertson, S, Saito, S, Scherjon, S, Staff, AC, Vatish, M & Robillard, PY 2019, 'A top priority in pre-eclampsia research: development of a reliable and inexpensive urinary screening test', The Lancet Global Health, vol. 7, no. 10, pp. e1312-e1313. https://doi.org/10.1016/S2214-109X(19)30319-5

TY - JOUR

T1 - A top priority in pre-eclampsia research

T2 - development of a reliable and inexpensive urinary screening test

AU - Scioscia, Marco

AU - Dekker, Gustaaf A.

AU - Chaouat, Gérard

AU - Dawonauth, Lalita

AU - Dechend, Ralf

AU - Goldman-Wohl, Debra

AU - Gumilar, Erry

AU - Karumanchi, S. Ananth

AU - Kell, Douglas B.

AU - Rademacher, Thomas W.

AU - Robertson, Sarah

AU - Saito, Shigeru

AU - Scherjon, Sicco

AU - Staff, Anne C.

AU - Vatish, Manu

AU - Robillard, Pierre Yves

N1 - Funding Information: TWR reports being a co-author on inositol phosphoglycans pre-eclampsia publications while on the University College London Medical School board. TWR was a coinventor on an InositolPhospho Glycan pre-eclampsia diagnostic patent, which has now lapsed. TWR provides laboratory reagents to academic groups for pre-eclampsia clinical trials. SAK reports consultancy work for Roche and Thermofisher and receiving a research grant from Siemens during the writing of this Comment; being a founder and advisory board member of Aggamin Pharmaceuticals outside the submitted work; Preeclampsia Biomarker patents with royalties paid to Beth Israel Deaconess Medical Center; and being a member of the Scientific Advisory Board for the Pre-eclampsia Foundation. All other authors declare no competing interests.

PY - 2019/10

Y1 - 2019/10

UR - http://www.scopus.com/inward/record.url?scp=85072179496&partnerID=8YFLogxK

U2 - 10.1016/S2214-109X(19)30319-5

DO - 10.1016/S2214-109X(19)30319-5

M3 - コメント/討論

C2 - 31537353

AN - SCOPUS:85072179496

SN - 2214-109X

VL - 7

SP - e1312-e1313

JO - The Lancet Global Health

JF - The Lancet Global Health

IS - 10

ER -